Financhill
Buy
58

VEEV Quote, Financials, Valuation and Earnings

Last price:
$238.27
Seasonality move :
17.41%
Day range:
$231.79 - $237.22
52-week range:
$170.25 - $258.93
Dividend yield:
0%
P/E ratio:
53.77x
P/S ratio:
13.99x
P/B ratio:
6.49x
Volume:
734.3K
Avg. volume:
1.2M
1-year change:
14.61%
Market cap:
$37.9B
Revenue:
$2.7B
EPS (TTM):
$4.33

Earnings Data

Next earnings date for VEEV
May 30
2025
Most recent earnings per share
$1.18
Missed by $0.40
(Mar 5/2025)
Consensus Estimate
$1.58
(Mar 5/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

VEEV Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
07/31/2025 Q3 $750.1M -- -- $1.79 --
05/30/2025 Q2 $728.4M -- -- $1.74 --
03/05/2025 Q1 $699.4M $720.9M $1.18 $1.58 -$0.40
12/05/2024 Q4 $684.3M $699.2M $1.13 $1.58 -$0.45
08/28/2024 Q3 $667.8M $676.2M $1.04 $1.53 -$0.49
05/30/2024 Q2 $642M $650.3M $0.98 $1.42 -$0.44
02/29/2024 Q1 $621.1M $630.6M $0.90 $1.30 -$0.40
12/06/2023 Q4 -- -- $0.83 $1.29 -$0.46
08/30/2023 Q3 -- -- $0.68 $1.13 -$0.45
05/31/2023 Q2 -- -- $0.81 $0.80 $0.01
03/01/2023 Q1 -- -- $1.16 $1.04 $0.12
12/01/2022 Q4 -- -- $0.67 $1.07 -$0.40
08/31/2022 Q3 -- -- $0.56 $1.01 -$0.45
06/01/2022 Q2 -- -- $0.62 $0.92 -$0.30
03/02/2022 Q1 -- -- $0.60 $0.88 -$0.28
12/01/2021 Q4 -- -- $0.65 $0.88 -$0.23
09/01/2021 Q3 -- -- $0.67 $0.86 -$0.19
05/27/2021 Q2 -- -- $0.71 $0.78 -$0.07
03/02/2021 Q1 -- -- $0.64 $0.68 -$0.04
12/01/2020 Q4 -- -- $0.60 $0.68 -$0.08
08/27/2020 Q3 -- -- $0.58 $0.64 -$0.06
05/28/2020 Q2 -- -- $0.54 $0.59 -$0.05
03/03/2020 Q1 -- -- $0.42 $0.52 -$0.10
11/26/2019 Q4 -- -- $0.52 $0.54 -$0.02
08/27/2019 Q3 -- -- $0.55 $0.49 $0.06
05/29/2019 Q2 -- -- $0.50 $0.45 $0.05
02/26/2019 Q1 -- -- $0.45 $0.40 $0.05
11/28/2018 Q4 -- -- $0.45 $0.38 $0.07
08/23/2018 Q3 -- -- $0.39 $0.34 $0.05
05/24/2018 Q2 -- -- $0.33 $0.31 $0.02
02/27/2018 Q1 -- -- $0.23 $0.21 $0.02
12/05/2017 Q4 -- -- $0.25 $0.21 $0.04
08/24/2017 Q3 -- -- $0.23 $0.20 $0.03
05/25/2017 Q2 -- -- $0.22 $0.18 $0.04
02/28/2017 Q1 -- -- $0.15 $0.11 $0.04
11/22/2016 Q4 -- -- $0.15 $0.10 $0.05
08/30/2016 Q3 -- -- $0.09 $0.08 $0.01
05/26/2016 Q2 -- -- $0.11 $0.07 $0.04
03/01/2016 Q1 -- -- $0.12 $0.07 $0.05
11/24/2015 Q4 -- -- $0.08 $0.10 -$0.02
08/27/2015 Q3 -- -- $0.10 $0.10 --

Veeva Systems Earnings Questions

  • How Much did Veeva Systems Generate in Revenue Last Quarter?

    Veeva Systems reported $720.9M worth of top line sales in its most recent quarter.

  • Did Veeva Systems Beat Earnings Last Quarter?

    Veeva Systems announced earnings per share of $1.18 which represents a miss of analyst forecast a $1.58 per share.

  • Is Veeva Systems Profitable?

    Veeva Systems reported $539.9M that represents $3.24 per share over the last quarter.

  • What is the Analyst Consensus for Veeva Systems EPS Next Year?

    Veeva Systems's earnings are forecast to grow from $4.32 per share to $6.45 per share next year representing an increase of 68.94%.

  • When is Veeva Systems's Earnings Date?

    Veeva Systems's next earnings date is May 30, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

CVX Vs XOM Stock, Which Energy Play Is Best?
CVX Vs XOM Stock, Which Energy Play Is Best?

Chevron (NYSE:CVX) and Exxon Mobil (NYSE:XOM) are two of the…

Is it Safe to Invest in Google With OpenAI Threats?
Is it Safe to Invest in Google With OpenAI Threats?

For the last 20 years, Google parent company Alphabet (NASDAQ:GOOG,…

Is Broadcom Stock a Millionaire Maker?
Is Broadcom Stock a Millionaire Maker?

Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Buy
60
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Buy
60
RGC alert for May 7

Regencell Bioscience Holdings [RGC] is up 22.52% over the past day.

Buy
77
FARO alert for May 7

Faro Technologies [FARO] is down 0% over the past day.

Buy
53
SRPT alert for May 7

Sarepta Therapeutics [SRPT] is down 21.54% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock